The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2R,3R,4S,5R)-2-(4-amino-5-(cyclopropylethynyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol ID: ALA4560390
PubChem CID: 155558648
Max Phase: Preclinical
Molecular Formula: C16H18N4O4
Molecular Weight: 330.34
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Nc1ncnc2c1c(C#CC1CC1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
Standard InChI: InChI=1S/C16H18N4O4/c17-14-11-9(4-3-8-1-2-8)5-20(15(11)19-7-18-14)16-13(23)12(22)10(6-21)24-16/h5,7-8,10,12-13,16,21-23H,1-2,6H2,(H2,17,18,19)/t10-,12-,13-,16-/m1/s1
Standard InChI Key: JDFHLPSWOYWYEA-XNIJJKJLSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
20.0903 -19.4933 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.8243 -20.2673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8617 -19.2434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8716 -18.4336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0936 -18.1800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3031 -20.9310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6066 -18.8362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0504 -20.5204 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.8227 -21.5921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0471 -21.3352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5762 -18.0314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5596 -19.6535 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.2741 -18.4414 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.2708 -19.2562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1302 -20.9384 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.5795 -17.2166 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.0742 -22.3750 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.3834 -21.8140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5054 -22.6190 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.8454 -17.4014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5956 -16.6179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3474 -15.8393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5166 -15.0440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7380 -15.2923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 1
3 1 1 0
4 3 2 0
5 7 2 0
6 2 1 0
7 1 1 0
8 2 1 0
9 6 1 0
10 8 1 0
11 4 1 0
12 3 1 0
13 14 1 0
14 12 2 0
6 15 1 6
16 11 1 0
9 17 1 6
10 18 1 1
19 18 1 0
4 5 1 0
9 10 1 0
13 11 2 0
5 20 1 0
20 21 3 0
21 22 1 0
23 22 1 0
24 23 1 0
22 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 330.34Molecular Weight (Monoisotopic): 330.1328AlogP: -0.61#Rotatable Bonds: 2Polar Surface Area: 126.65Molecular Species: NEUTRALHBA: 8HBD: 4#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.46CX Basic pKa: 4.92CX LogP: -0.02CX LogD: -0.02Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.54Np Likeness Score: 0.90
References 1. Spurr SS, Bayle ED, Yu W, Li F, Tempel W, Vedadi M, Schapira M, Fish PV.. (2016) New small molecule inhibitors of histone methyl transferase DOT1L with a nitrile as a non-traditional replacement for heavy halogen atoms., 26 (18): [PMID:27485386 ] [10.1016/j.bmcl.2016.07.041 ]